Who owns CNS Pharmaceuticals Inc?
- Ticker: CNSP
- CUSIP Number: 18978h508
Tip: Access positions for across all investors
Analyze quarterly positions in CNS Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of CNS Pharmaceuticals stock
Who bought or sold CNS Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 136k | $649k | 196% | Jun 2026 |
|
| ADAR1 Capital Management | 70k | $335k | 100% | Jun 2026 |
|
| Stonepine Capital Management | 42k | $199k | -32% | Jun 2026 |
|
| Boothbay Fund Management | 14k | $65k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 10k | $49k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 7.0k | $33k | 100% | Jun 2026 |
|
| UBS Group | 1.5k | $6.8k | 100% | Jun 2026 |
|
| Tower Research Capital | 799.00 | $3.8k | -39% | Jun 2026 |
|
| Barclays | 19.00 | $91.000500 | 100% | Jun 2026 |
|
| Barrett & Company | 8.00 | $38.000000 | 0% | Jun 2026 |
|
| Danske Bank A/s | 1.00 | $5.000000 | 0% | Jun 2026 |
|
| Citigroup | 1.00 | $2.000000 | 100% | Mar 2026 |
|
Who sold out of CNS Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Geode Capital Management | Mar 2026 | 23k | $56k |
| MAI Wealth Advisors | Mar 2026 | 3.00 | $8.000100 |
| Caitong International Asset Management | Mar 2026 | 1.00 | $2.000000 |